Imaging the Circumnuclear Region of NGC 1365 with Chandra

We present the first Chandra/ACIS imaging study of the circumnuclear region of the nearby Seyfert galaxy NGC 1365. The X-ray emission is resolved into point-like sources and complex, extended emission. The X-ray morphology of the extended emission shows a biconical soft X-ray emission region extending ~5 kpc in projection from the nucleus, coincident with the high excitation outflow cones seen in optical emission lines particularly to the northwest. Harder X-ray emission is detected from a kpc-diameter circumnuclear ring, coincident with the star-forming ring prominent in the Spitzer mid-infrared images; this X-ray emission is partially obscured by the central dust lane of NGC 1365. Spectral fitting of spatially separated components indicates a thermal plasma origin for the soft extended X-ray emission (kT=0.57 keV). Only a small amount of this emission can be due to photoionization by the nuclear source. Detailed comparison with [OIII]5007 observations shows the hot interstellar medium (ISM) is spatially anticorrelated with the [OIII] emitting clouds and has thermal pressures comparable to those of the [OIII] medium, suggesting that the hot ISM acts as a confining medium for the cooler photoionized clouds. The abundance ratios of the hot ISM are fully consistent with the theoretical values for enrichment from Type II supernovae, suggesting that the hot ISM is a wind from the starburst circumnuclear ring. X-ray emission from a ~450 pc long nuclear radio jet is also detected to the southeast.Comment: Accepted for publication in The Astrophysical Journal (April 2009). 50 pages, 13 figures, 6 table

Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel

BackgroundDespite many publications about cerebral cavernous malformations (CCMs), controversy remains regarding diagnostic and management strategies.ObjectiveTo develop guidelines for CCM management.MethodsThe Angioma Alliance ( www.angioma.org ), the patient support group in the United States advocating on behalf of patients and research in CCM, convened a multidisciplinary writing group comprising expert CCM clinicians to help summarize the existing literature related to the clinical care of CCM, focusing on 5 topics: (1) epidemiology and natural history, (2) genetic testing and counseling, (3) diagnostic criteria and radiology standards, (4) neurosurgical considerations, and (5) neurological considerations. The group reviewed literature, rated evidence, developed recommendations, and established consensus, controversies, and knowledge gaps according to a prespecified protocol.ResultsOf 1270 publications published between January 1, 1983 and September 31, 2014, we selected 98 based on methodological criteria, and identified 38 additional recent or relevant publications. Topic authors used these publications to summarize current knowledge and arrive at 23 consensus management recommendations, which we rated by class (size of effect) and level (estimate of certainty) according to the American Heart Association/American Stroke Association criteria. No recommendation was level A (because of the absence of randomized controlled trials), 11 (48%) were level B, and 12 (52%) were level C. Recommendations were class I in 8 (35%), class II in 10 (43%), and class III in 5 (22%).ConclusionCurrent evidence supports recommendations for the management of CCM, but their generally low levels and classes mandate further research to better inform clinical practice and update these recommendations. The complete recommendations document, including the criteria for selecting reference citations, a more detailed justification of the respective recommendations, and a summary of controversies and knowledge gaps, was similarly peer reviewed and is available on line www.angioma.org/CCMGuidelines